TODD STRATEGY GROUP

Lobbying for GENEOSCOPY, INC. · A life sciences company focused on developing diagnostic tests for gastrointestinal health

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Missouri · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Colorectal Cancer Screening Access. Medicare Quality Measures USPSTF colorectal cancer screening guidelines.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.